Pliant Therapeutics Inc. Made Headway

Mon, Jan 23, 2023 at 07:01 PM
Pliant Therapeutics Inc. Made Headway

Pliant Therapeutics Inc. (PLRX:NASDAQ) rocketted at $30.28, representing a gain of 34.5%. On Mon, Jan 23, 2023, PLRX:NASDAQ hit a New 2-Week High of $30.28. The stock got featured on our News Catalysts scanner on Mon, Jan 23, 2023 at 04:55 PM in the 'PUBLIC OFFERING' category. From Mon, Jan 09, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days

About Pliant Therapeutics Inc. (PLRX:NASDAQ)

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.